Top

Annals of Hematology

Published in:

01-11-2016 | Letter to the Editor

Functional acute liver failure after treatment with pegylated asparaginase in a patient with acute lymphoblastic leukemia: potential impact of plasmapheresis

Authors: Wibke Göpel, Ulf Schnetzke, Andreas Hochhaus, Sebastian Scholl

Published in: Annals of Hematology | Issue 11/2016

Excerpt

Dear Editor, …

Patil S, Coutsouvelis J, Spencer A (2011) Asparaginase in the management of adult acute lymphoblastic leukaemia: is it used appropriately? Cancer Treat Rev 37:202–207CrossRefPubMed

Kawedia JD, Rytting ME (2014) Asparaginase in acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk 14(Suppl):S14–S17CrossRefPubMed

Verma N, Kumar K, Kaur G, Anand S (2007) L-asparaginase: a promising chemotherapeutic agent. Crit Rev Biotechnol 27:45–62CrossRefPubMed

Asselin B, Rizzari C (2015) Asparaginase pharmacokinetics and implications of therapeutic drug monitoring. Leuk Lymphoma 56:2273–2280CrossRefPubMedPubMedCentral

Hijiya N, van der Sluis IM (2016) Asparaginase-associated toxicity in children with acute lymphoblastic leukemia. Leuk Lymphoma 57:748–757CrossRefPubMed

Bodmer M, Sulz M, Stadlmann S et al (2006) Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase. Digestion 74:28–32CrossRefPubMed

Tsutsui M, Koike M, Komatsu N (2012) Fulminant hepatitis possibly caused by L-asparaginase during induction chemotherapy in a patient with acute lymphoblastic leukemia. Rinsho Ketsueki 53:531–534PubMed

Bilgir O, Calan M, Bilgir F et al (2013) An experience with plasma exchange treatment of acute lymphoblastic leukemia in a case with fulminant hepatitis related to L-asparaginase. Transfus Apher Sci 49:328–330CrossRefPubMed

Title: Functional acute liver failure after treatment with pegylated asparaginase in a patient with acute lymphoblastic leukemia: potential impact of plasmapheresis
Authors: Wibke Göpel
Ulf Schnetzke
Andreas Hochhaus
Sebastian Scholl
Publication date: 01-11-2016
Publisher: Springer Berlin Heidelberg
Published in: Annals of Hematology / Issue 11/2016
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-016-2773-0

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Functional acute liver failure after treatment with pegylated asparaginase in a patient with acute lymphoblastic leukemia: potential impact of plasmapheresis

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 11/2016

Single agent blinatumumab as frontline therapy for an 85-year-old patient with B cell precursor acute lymphoblastic leukemia

Abnormal expression of inflammatory genes in placentas of women with sickle cell anemia and sickle hemoglobin C disease

Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)—ViLen-01 protocol

The predictive value of selected serum microRNAs for acute GVHD by TaqMan MicroRNA arrays

Cyclosporin A for persistent or chronic immune thrombocytopenia in children

The global burden of pulmonary hypertension in sickle cell disease: a systematic review and meta-analysis

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page